Noelle K. Eder - 07 Mar 2025 Form 4 Insider Report for Cigna Group (CI)

Signature
Matthew Arnold, attorney-in-fact
Issuer symbol
CI
Transactions as of
07 Mar 2025
Net transactions value
-$3,182,080
Form type
4
Filing time
11 Mar 2025, 17:11:49 UTC
Previous filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Sale $3,182,080 -9,944 -43% $320.00 13,406 07 Mar 2025 Direct F1
holding CI Common Stock, $.01 Par Value 184 07 Mar 2025 By 401(k) F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Remarks:

EVP, Global Chief Information Officer